DE69327330T2 - Verfahren zum bekämpfen der pneumocystis carinii pneumonie und dafür verwendbare verbindungen - Google Patents

Verfahren zum bekämpfen der pneumocystis carinii pneumonie und dafür verwendbare verbindungen

Info

Publication number
DE69327330T2
DE69327330T2 DE69327330T DE69327330T DE69327330T2 DE 69327330 T2 DE69327330 T2 DE 69327330T2 DE 69327330 T DE69327330 T DE 69327330T DE 69327330 T DE69327330 T DE 69327330T DE 69327330 T2 DE69327330 T2 DE 69327330T2
Authority
DE
Germany
Prior art keywords
combating
pneumocystis carinii
compounds
pneumonie
bis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69327330T
Other languages
English (en)
Other versions
DE69327330D1 (de
Inventor
Richard R Tidwell
Christine C Dykstra
James E Hall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of North Carolina at Chapel Hill
University of North Carolina System
Original Assignee
University of North Carolina at Chapel Hill
University of North Carolina System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of North Carolina at Chapel Hill, University of North Carolina System filed Critical University of North Carolina at Chapel Hill
Application granted granted Critical
Publication of DE69327330D1 publication Critical patent/DE69327330D1/de
Publication of DE69327330T2 publication Critical patent/DE69327330T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DE69327330T 1992-10-13 1993-10-04 Verfahren zum bekämpfen der pneumocystis carinii pneumonie und dafür verwendbare verbindungen Expired - Fee Related DE69327330T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/958,696 US5428051A (en) 1992-10-13 1992-10-13 Methods of combating pneumocystis carinii pneumonia and compounds useful therefor
PCT/US1993/009477 WO1994008580A1 (en) 1992-10-13 1993-10-04 Methods of combating pneumocystis carinii pneumonia and compounds useful therefor

Publications (2)

Publication Number Publication Date
DE69327330D1 DE69327330D1 (de) 2000-01-20
DE69327330T2 true DE69327330T2 (de) 2000-08-24

Family

ID=25501203

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69327330T Expired - Fee Related DE69327330T2 (de) 1992-10-13 1993-10-04 Verfahren zum bekämpfen der pneumocystis carinii pneumonie und dafür verwendbare verbindungen

Country Status (10)

Country Link
US (2) US5428051A (de)
EP (1) EP0664703B1 (de)
JP (1) JP2888453B2 (de)
AT (1) ATE187641T1 (de)
AU (1) AU675092B2 (de)
BR (1) BR9307235A (de)
CA (1) CA2104196C (de)
DE (1) DE69327330T2 (de)
NZ (1) NZ257001A (de)
WO (1) WO1994008580A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5428051A (en) * 1992-10-13 1995-06-27 University Of North Carolina Methods of combating pneumocystis carinii pneumonia and compounds useful therefor
IL111011A0 (en) * 1993-09-22 1994-11-28 Wellcome Found Bisbenzimidazole compounds, their preparation and pharmaceutical compositions containing them
US6815461B1 (en) * 1994-01-20 2004-11-09 The University Of North Carolina At Chapel Hill Method of inhibiting retroviral integrase
US5629348A (en) * 1994-11-14 1997-05-13 Nzym, Inc. Methods and compositions for treating septoria infections
WO1996015104A2 (en) * 1994-11-14 1996-05-23 Nzym, Inc. Methods and compositions for treating phytopathogenic fungi infections
US5637621A (en) * 1994-11-14 1997-06-10 Nzym, Inc. Methods and compositions for treating Botrytis infections
US6562854B2 (en) 1994-12-14 2003-05-13 Axys Pharmaceuticals, Inc. Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders
US5643935A (en) * 1995-06-07 1997-07-01 The University Of North Carolina At Chapel Hill Method of combatting infectious diseases using dicationic bis-benzimidazoles
US5723495A (en) * 1995-11-16 1998-03-03 The University Of North Carolina At Chapel Hill Benzamidoxime prodrugs as antipneumocystic agents
US5935982A (en) * 1997-02-28 1999-08-10 The University Of North Carolina At Chapel Hill Methods of treating retroviral infection and compounds useful therefor
US6150379A (en) * 1997-11-26 2000-11-21 Axys Pharmaceuticals, Inc. Compounds and compositions as anticoagulants
US6635668B1 (en) * 1998-07-22 2003-10-21 The University Of North Carolina At Chapel Hill Imidazoline receptor binding compounds
ES2275362T3 (es) 1998-09-17 2007-06-01 The University Of North Carolina At Chapel Hill Actividad antifungica de moleculas dicationicas.
WO2000075117A1 (en) 1999-06-04 2000-12-14 Elan Pharma International Ltd. Compositions and methods for inhibiting cell death
US6569853B1 (en) * 2000-11-06 2003-05-27 Combinatorx, Incorporated Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
JP2005504053A (ja) * 2001-08-31 2005-02-10 ニューロケム （インターナショナル） リミテッド アミロイドーシス治療のためのアミジン誘導体
WO2004002430A2 (en) * 2002-06-28 2004-01-08 Combinatorx Incorporated Combinations for the treatment of fungal infections
US20050054708A1 (en) * 2003-07-28 2005-03-10 Nichols Matthew James Combinations of drugs for the treatment of neoplasms
WO2005020913A2 (en) * 2003-08-25 2005-03-10 Combinatorx, Incorporated Formulations, conjugates, and combinations of drugs for the treatment of neoplasms
US20050158320A1 (en) * 2003-11-12 2005-07-21 Nichols M. J. Combinations for the treatment of proliferative diseases
US20050100508A1 (en) * 2003-11-12 2005-05-12 Nichols M. J. Methods for identifying drug combinations for the treatment of proliferative diseases
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
JP2008500965A (ja) * 2004-03-17 2008-01-17 エムペックス・ファーマシューティカルズ・インコーポレーテッド 細菌の排出ポンプ阻害剤の使用および投与
US7994225B2 (en) * 2004-03-17 2011-08-09 Rempex Pharmaceuticals, Inc. Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
DE102004031656A1 (de) * 2004-06-30 2006-01-19 Merck Patent Gmbh Tetrahydrochinoline
DE102007013854A1 (de) 2007-03-20 2008-09-25 Merck Patent Gmbh Tetrahydrochinoline
DE102007013855A1 (de) 2007-03-20 2008-09-25 Merck Patent Gmbh Substituierte Tetrahydrochinoline
DE102007013856A1 (de) 2007-03-20 2008-09-25 Merck Patent Gmbh Substituierte Tetrahydropyrrolochinoline
EP2194981B1 (de) * 2007-10-05 2011-11-23 Université de Mons-Hainaut Bisbenzimidazole und mittel gegen malaria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933347A (en) * 1988-10-25 1990-06-12 University Of North Carolina At Chapel Hill Diamidines and bis(imidazolines) for the treatment of and prophylaxis against pneumocystis carinii pneumonia
AU626033B2 (en) * 1988-10-25 1992-07-23 Government Of The United States Of America, As Represented By The Secretary Of The Army, The Methods for the treatment and prophylaxis of pneumocystis carinii pneumonia and other diseases and compounds and formulations for use in said methods
US4963589A (en) * 1988-10-25 1990-10-16 The University Of North Carolina At Chapel Hill Methods for treating Giardia lamblia
US5428051A (en) * 1992-10-13 1995-06-27 University Of North Carolina Methods of combating pneumocystis carinii pneumonia and compounds useful therefor

Also Published As

Publication number Publication date
US5578631A (en) 1996-11-26
CA2104196C (en) 2001-03-27
BR9307235A (pt) 1999-08-24
AU5299593A (en) 1994-05-09
NZ257001A (en) 1997-06-24
US5428051A (en) 1995-06-27
CA2104196A1 (en) 1994-04-14
EP0664703A4 (de) 1997-05-21
AU675092B2 (en) 1997-01-23
EP0664703B1 (de) 1999-12-15
JPH08502294A (ja) 1996-03-12
JP2888453B2 (ja) 1999-05-10
WO1994008580A1 (en) 1994-04-28
DE69327330D1 (de) 2000-01-20
ATE187641T1 (de) 2000-01-15
EP0664703A1 (de) 1995-08-02

Similar Documents

Publication Publication Date Title
DE69327330D1 (de) Verfahren zum bekämpfen der pneumocystis carinii pneumonie und dafür verwendbare verbindungen
IL93556A0 (en) Stabilized nitric oxide-primary amine complexes useful as cardiovascular agents
DE69328192D1 (de) Injizierbare Arzneizubereitungen enthaltend Taxanderivate
MX9505182A (es) Composicion terapeutica para aplicacion topica, que contiene un antagonista de la substancia p.
ATE142494T1 (de) 2-arylthiazolderivat sowie dieses enthaltendes arzneimittel
GR3022631T3 (en) Trifluoromethylketone derivatives of peptides having HLE inhibiting activity, their preparation and pharmaceutical composition
ATE143601T1 (de) Verwendung von rifamycinderivaten zur herstellung eines arzneimittels zur behandlung der toxoplasmose
FI944823A (fi) Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
BR8902929A (pt) Artigo vendavel
ATE385496T1 (de) Dihydrobenzofurane und verwandte verbindungen als entzündungshemmende mittel
UA42730C2 (uk) Похідні тетрагідроізохіноліну і їх фармацевтично прийнятні солі у вигляді індивідуальних енантіомерів, рацематів або інших сумішей енантіомерів
HUP9901448A2 (hu) Új gyógyászati alkalmazás
MX9700726A (es) Dihidrobenzofurano y compuestos relacionados, utiles como agentes antiinflamatorios.
NO923198L (no) Terapeutiske midler
IE902273L (en) Compositions of 5-phenyl-2-furan esters amides and ketones
FI892685A0 (fi) Menetelmä uusien, sytostaattisesti vaikuttavien antrasykliinijohdannaisten valmistamiseksi
ES2066605T3 (es) Nuevas ureas y tioureas, su preparacion y su aplicacion en terapeutica.
ATE228359T1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
TH14009A (th) สารปฏิชีวนะ
RU95120104A (ru) Производное серина
IT1281262B1 (it) Siringa per l'iniezione di grandi quantita' di liquido, come liquido disinfettante, conservativo, medicinale o simili
TH14009EX (th) สารปฏิชีวนะ

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee